La Yi

694 total citations
20 papers, 496 citations indexed

About

La Yi is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, La Yi has authored 20 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Immunology. Recurrent topics in La Yi's work include Asthma and respiratory diseases (13 papers), IL-33, ST2, and ILC Pathways (5 papers) and Respiratory and Cough-Related Research (3 papers). La Yi is often cited by papers focused on Asthma and respiratory diseases (13 papers), IL-33, ST2, and ILC Pathways (5 papers) and Respiratory and Cough-Related Research (3 papers). La Yi collaborates with scholars based in China and United States. La Yi's co-authors include Jingcheng Dong, Ying Wei, Fangzhou Teng, Jingjing Qin, Xueyi Zhu, Tulake Wuniqiemu, Weifeng Tang, Jie Cui, Ming Dong and Qin Bian and has published in prestigious journals such as Frontiers in Immunology, Journal of Ethnopharmacology and BioMed Research International.

In The Last Decade

La Yi

20 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
La Yi China 13 201 144 124 106 88 20 496
Xueyi Zhu China 12 178 0.9× 119 0.8× 122 1.0× 107 1.0× 87 1.0× 20 474
Fangzhou Teng China 14 215 1.1× 155 1.1× 151 1.2× 127 1.2× 94 1.1× 22 557
Tulake Wuniqiemu China 11 160 0.8× 102 0.7× 109 0.9× 92 0.9× 64 0.7× 16 416
Liangchang Li China 15 265 1.3× 62 0.4× 120 1.0× 164 1.5× 53 0.6× 38 584
Entezar Mehrabi Nasab Iran 10 127 0.6× 113 0.8× 136 1.1× 123 1.2× 29 0.3× 36 460
Hongmei Piao China 11 139 0.7× 54 0.4× 93 0.8× 113 1.1× 31 0.4× 18 365
Wangjian Zha China 8 189 0.9× 51 0.4× 87 0.7× 66 0.6× 100 1.1× 15 379
Linfu Zhou China 9 120 0.6× 102 0.7× 147 1.2× 102 1.0× 21 0.2× 20 398
Yunxiao Shang China 14 240 1.2× 116 0.8× 114 0.9× 125 1.2× 106 1.2× 17 486
Yanqin Qin China 10 250 1.2× 103 0.7× 39 0.3× 112 1.1× 88 1.0× 18 493

Countries citing papers authored by La Yi

Since Specialization
Citations

This map shows the geographic impact of La Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by La Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites La Yi more than expected).

Fields of papers citing papers by La Yi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by La Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by La Yi. The network helps show where La Yi may publish in the future.

Co-authorship network of co-authors of La Yi

This figure shows the co-authorship network connecting the top 25 collaborators of La Yi. A scholar is included among the top collaborators of La Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with La Yi. La Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gao, Zhen, Jingjing Qin, Wenqian Wang, et al.. (2023). Trends of therapy in the treatment of asthma. Therapeutic Advances in Respiratory Disease. 17. 2683735076–2683735076. 13 indexed citations
3.
Tang, Weifeng, Jingjing Qin, Fangzhou Teng, et al.. (2023). Regulation of ferroptosis and ACSL4-15LO1 pathway contributed to the anti-asthma effect of acupuncture. International Immunopharmacology. 115. 109670–109670. 16 indexed citations
4.
Cui, Jie, Weifeng Tang, Wenqian Wang, et al.. (2023). Acteoside alleviates asthma by modulating ROS-responsive NF-κB/MAPK signaling pathway. International Immunopharmacology. 116. 109806–109806. 7 indexed citations
5.
Teng, Fangzhou, Jie Cui, Xueyi Zhu, et al.. (2022). Acupoint Catgut‐Embedding Therapy Inhibits NF‐κB/COX‐2 Pathway in an Ovalbumin‐Induced Mouse Model of Allergic Asthma. BioMed Research International. 2022(1). 1764104–1764104. 10 indexed citations
6.
7.
Dong, Ming, Weifeng Tang, Jingjing Qin, et al.. (2022). Ferroptosis, novel therapeutics in asthma. Biomedicine & Pharmacotherapy. 153. 113516–113516. 25 indexed citations
8.
Wuniqiemu, Tulake, Fangzhou Teng, Jingjing Qin, et al.. (2022). Iristectorigenin A exerts novel protective properties against airway inflammation and mucus hypersecretion in OVA-induced asthmatic mice. Phytomedicine. 104. 154252–154252. 7 indexed citations
9.
Cui, Jie, Fangzhou Teng, La Yi, et al.. (2021). RNA-Seq Expression Analysis of Chronic Asthmatic Mice with Bu-Shen-Yi-Qi Formula Treatment and Prediction of Regulated Gene Targets of Anti-Airway Remodeling. Evidence-based Complementary and Alternative Medicine. 2021. 1–9. 4 indexed citations
10.
Teng, Fangzhou, Weifeng Tang, Tulake Wuniqiemu, et al.. (2021). N6-Methyladenosine Methylomic Landscape of Lung Tissues in Murine Acute Allergic Asthma. Frontiers in Immunology. 12. 740571–740571. 18 indexed citations
11.
Qin, Jingjing, Tulake Wuniqiemu, Ying Wei, et al.. (2021). Proteomics analysis reveals suppression of IL-17 signaling pathways contributed to the therapeutic effects of Jia-Wei Bu-Shen-Yi-Qi formula in a murine asthma model. Phytomedicine. 95. 153803–153803. 10 indexed citations
12.
Wuniqiemu, Tulake, Fangzhou Teng, Qin Bian, et al.. (2021). Luteolin inhibits autophagy in allergic asthma by activating PI3K/Akt/mTOR signaling and inhibiting Beclin-1-PI3KC3 complex. International Immunopharmacology. 94. 107460–107460. 87 indexed citations
13.
Zhu, Xueyi, Yuxue Cao, Mengmeng Chen, et al.. (2021). Cycloastragenol alleviates airway inflammation in asthmatic mice by inhibiting autophagy. Molecular Medicine Reports. 24(5). 17 indexed citations
14.
Tang, Weifeng, Ming Dong, Fangzhou Teng, et al.. (2021). Environmental allergens house dust mite‑induced asthma is associated with ferroptosis in the lungs. Experimental and Therapeutic Medicine. 22(6). 1483–1483. 43 indexed citations
15.
Zhu, Xueyi, Jie Cui, La Yi, et al.. (2020). The Role of T Cells and Macrophages in Asthma Pathogenesis: A New Perspective on Mutual Crosstalk. Mediators of Inflammation. 2020. 1–14. 40 indexed citations
16.
Yi, La, Jie Cui, Weifeng Tang, et al.. (2020). Formononetin Attenuates Airway Inflammation and Oxidative Stress in Murine Allergic Asthma. Frontiers in Pharmacology. 11. 533841–533841. 69 indexed citations
17.
Tang, Weifeng, Ming Dong, Fangzhou Teng, et al.. (2020). TMT-based quantitative proteomics reveals suppression of SLC3A2 and ATP1A3 expression contributes to the inhibitory role of acupuncture on airway inflammation in an OVA-induced mouse asthma model. Biomedicine & Pharmacotherapy. 134. 111001–111001. 56 indexed citations
18.
Wuniqiemu, Tulake, Jingjing Qin, Fangzhou Teng, et al.. (2020). Quantitative proteomic profiling of targeted proteins associated with Loki Zupa Decoction Treatment in OVA-Induced asthmatic mice. Journal of Ethnopharmacology. 266. 113343–113343. 15 indexed citations
19.
Cui, Jie, Ming Dong, La Yi, et al.. (2020). Acupuncture inhibited airway inflammation and group 2 innate lymphoid cells in the lung in an ovalbumin-induced murine asthma model. Acupuncture in Medicine. 39(3). 217–225. 8 indexed citations
20.
Wang, Wenqian, Ming Dong, Jie Cui, et al.. (2019). NME4 may enhance non‑small cell lung cancer progression by overcoming cell cycle arrest and promoting cellular proliferation. Molecular Medicine Reports. 20(2). 1629–1636. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xueyi Zhu Breakdown of academic impact, for papers by Fangzhou Teng Breakdown of academic impact, for papers by Tulake Wuniqiemu Breakdown of academic impact, for papers by Liangchang Li Breakdown of academic impact, for papers by Entezar Mehrabi Nasab Breakdown of academic impact, for papers by Hongmei Piao Breakdown of academic impact, for papers by Wangjian Zha Breakdown of academic impact, for papers by Linfu Zhou Breakdown of academic impact, for papers by Yunxiao Shang Breakdown of academic impact, for papers by Yanqin Qin
Rankless by CCL
2026